Skip to main content

Table 2 Summary of patients’ characteristics

From: Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B

 

N = 619

Age1(years)

38.9 ± 11.5

Gender

Male

506 (81.7%)

Female

113 (18.3%)

Inflammation stage

0-1

82 (13.2%)

2

150 (24.2%)

3

265 (42.8%)

4

122 (19.7%)

Fibrosis stage

0-1

151 (24.4%)

2

136 (22.0%)

3

129 (20.8%)

4

203 (32.8%)

AFP (ng/ml)2

4.7 (2.5, 13.7)

ALT (U/L)2

93.0 (46.0, 241.0)

AST (U/L)2

63.0 (37.0, 135.0)

GGT (UL)2

54.0 (31.0, 98.0)

APRI (AST/PLT ratio)2

0.41 (0.21, 0.83)

  1. Two subjects with inflammation stage 0, and 80 subjects with inflammation stage 1 were combined into one group; 27 subjects with fibrosis stage 0, and 124 subjects with fibrosis stage 1 were combined into one group.
  2. 1Data presented as mean with standard deviation. 2Data presented as median with inter-quartile range. Other data are presented as count and percentage.